Compare MLM & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLM | HLN |
|---|---|---|
| Founded | 1993 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Package Goods/Cosmetics |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.8B | 38.5B |
| IPO Year | 1996 | 2021 |
| Metric | MLM | HLN |
|---|---|---|
| Price | $514.38 | $9.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 5 |
| Target Price | ★ $626.00 | $10.40 |
| AVG Volume (30 Days) | 834.9K | ★ 22.1M |
| Earning Date | 11-04-2026 | 07-30-2026 |
| Dividend Yield | 0.66% | ★ 2.15% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 32.64 | N/A |
| Revenue | ★ $6,150,000,000.00 | N/A |
| Revenue This Year | $26.16 | $2.35 |
| Revenue Next Year | $20.53 | $3.29 |
| P/E Ratio | ★ $15.64 | $49.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $464.92 | $8.38 |
| 52 Week High | $710.97 | $11.28 |
| Indicator | MLM | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 48.98 | 45.14 |
| Support Level | $467.56 | $9.08 |
| Resistance Level | $583.95 | $9.32 |
| Average True Range (ATR) | 18.01 | 0.18 |
| MACD | -3.10 | -0.01 |
| Stochastic Oscillator | 14.25 | 75.00 |
Martin Marietta is a leading US producer of construction aggregates, having produced roughly 200 million tons in 2025. Its aggregate reserves represent approximately 85 years of supply at 2025 production levels. Over the past several years, the company has increased its exposure to aggregates while reducing its presence in cement and downstream businesses such as concrete and asphalt. More recently, Martin Marietta expanded into an aggregate-adjacent business through its acquisition of Lhoist North America, the largest US producer of lime. The company operates across 28 states, with smaller operations in Canada and the Bahamas.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.